Market capitalization | CHF1.97b |
Enterprise Value | CHF2.41b |
P/E (TTM) P/E ratio | 63.19 |
EV/FCF (TTM) EV/FCF | 17.78 |
EV/Sales (TTM) EV/Sales | 2.18 |
P/S ratio (TTM) P/S ratio | 1.77 |
P/B ratio (TTM) P/B ratio | 5.33 |
Dividend yield | 2.77% |
Last dividend (FY24) | CHF3.20 |
As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.
5 Analysts have issued a Dätwyler forecast:
5 Analysts have issued a Dätwyler forecast:
Dec '24 |
+/-
%
|
||
Revenue | 1,108 1,108 |
4%
4%
|
|
Gross Profit | 238 238 |
1%
1%
|
|
EBITDA | 176 176 |
2%
2%
|
EBIT (Operating Income) EBIT | 96 96 |
4%
4%
|
Net Profit | 31 31 |
53%
53%
|
In millions CHF.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Dätwyler Holding AG engages in the supply of system-critical elastomer components for injectable drug delivery systems. It operates through the Healthcare Solutions and Industrial Solutions segments. The Healthcare Solutions segment offers system-critical components for containers and delivery systems for injectable drugs and diagnostics in the pharmaceutical and medical markets. The Industrial Solutions segment manufactures customized system-critical components for applications in the mobility, food, and beverage, and general industry markets. The company was founded in 1915 and is headquartered in Altdorf, Switzerland.
Head office | Switzerland |
CEO | Volker Cwielong |
Employees | 8,030 |
Founded | 1915 |
Website | www.daetwyler.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.